Suneel Gupta, Chief Development Officer at Protagonist Therapeutics, Inc (PTGX), sold 245,256 shares at $45.50 ($11.3M) on 2024-11-26, disclosed to the SEC on 2024-11-27.
Open-market sale of $11.3M PTGX by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.04 | 103,437 | $4.8M | 42.3% |
| 2 | $46.04 | 103,437 | $4.8M | 42.3% |
| 3 | $45.50 | 19,191 | $873K | 7.7% |
| 4 | $45.50 | 19,191 | $873K | 7.7% |
| Total | $45.96 avg | 245,256 | $11.3M | 100% |
| Filing → |